ПАДЦЕВ

Описание товара

About ПАДЦЕВ

ПАДЦЕВ is a prescription medication containing the active ingredient Enfortumab vedotin, a monoclonal antibody-drug conjugate used in the treatment of certain types of cancer. It is specifically indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma who have previously received chemotherapy.

Key Benefits & Uses

• Treatment of locally advanced or metastatic urothelial carcinoma
• Monotherapy for patients who have previously received chemotherapy
• Targeted therapy for cancer cells expressing Nectin-4

Active Ingredient & Action

Enfortumab vedotin works by binding to Nectin-4, a protein expressed on the surface of certain cancer cells, and delivering a cytotoxic agent that inhibits cell division and induces apoptosis. This targeted approach helps to minimize harm to healthy cells and reduce side effects.

Important Notes

ПАДЦЕВ is available only by prescription and should be used under the guidance of a qualified healthcare professional. Patients should be monitored for potential side effects, including fatigue, nausea, and skin reactions. It is essential to follow the recommended dosing schedule and report any concerns or changes in health status to a healthcare provider.